Beyond the lab: immuno-oncology

Read this in-depth analyses and insights from leading experts in the field focusing on treatments, new technologies and engineered bacteria.

Beyond the Lab Immunooncology graphic

Download this exclusive report to discover key immuno-oncology advancements and breakthroughs including targets playing crucial roles in multiple tumour survival pathways, how to improve the analysis of single-cell transcriptomic data and a new wave of promising NK cell therapeutics.

Expert insights from:

  • Dr Catherine Pickering, CEO of iOnctura
  • Dr Espen Basmo Ellingsen, University of Oslo
  • Dr Tong Huo, Sino Biological
  • Dr Vanda Lopes, BPS Bioscience

From the discovery of IOA-289, an autotaxin inhibitor with potential in pancreatic cancer therapy, to the development of Spectra, an open-source computational method revolutionising single-cell transcriptomic data analysis, this exclusive report showcases cutting-edge research and innovative approaches. Discover insights into macrophage phenotype optimisation for improved immunotherapy outcomes and mRNA therapies for glioblastoma demonstrate the evolving landscape of immune-based cancer treatments. 

Download now to read more about:

  • Combining autotaxin and TGF-β inhibitors in cancer
  • New insights to improve immunotherapy treatments
  • The promise of NK cell therapeutics
  • Macrophage phenotype insights
  • New technology optimising mesenchymal stem cell extraction
  • Cancer-killing T cells enhanced by engineered bacteria.


Interested? Please register your details in the box to receive this exclusive content.

This Beyond the Lab report is brought to you in association with:

Sino Biological Logo